ResearchHub Text Logo
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify IdentityVerified
CommunitySupportAbout
TermsPrivacyIssuesDocs
Paper
RH Logo
RH LogoRH Logo
Paper
0
Paper
Conversation
Grants
Reviews
Document
Submit new version
Download
Flag content
0

TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer

Oncology
Internal Medicine
Cancer Research
Show More
Authors
Julio Ricarte-Filho,Erin Reichenberger
Kevin Hinkle,Amber Isaza,Andrew Bauer,Aime Franco
+4 authors
,Julio Ricarte‐Filho
Journal
Thyroid
Published
Aug 6, 2024
DOI
10.1089/thy.2024.0224
Show more
Save
TipTip
Document
Submit new version
Download
Flag content
0
TipTip
Save
Document
Submit new version
Download
Flag content
Paper
Conversation
Grants
Reviews

Abstract

Receptor Tyrosine Kinase (RTK) fusions of RET, NTRK1/3, and ALK are enriched among pediatric thyroid cancer patients with metastatic and persistent disease and their oncoproteins represent attractive drug targets.

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.